BioLineRx Ltd. (BLRX.TA)
ILA 1.9
(5.56%)
ILA 1.9
(5.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -49.69 Million USD | -70.44% |
| 2022 | -29.15 Million USD | -17.68% |
| 2021 | -24.77 Million USD | -8.07% |
| 2020 | -22.92 Million USD | 18.44% |
| 2019 | -28.11 Million USD | -9.79% |
| 2018 | -25.6 Million USD | -1.45% |
| 2017 | -25.24 Million USD | -52.85% |
| 2016 | -16.51 Million USD | -1.96% |
| 2015 | -16.19 Million USD | -2.18% |
| 2014 | -15.85 Million USD | 10.08% |
| 2013 | -17.62 Million USD | 19.26% |
| 2012 | -21.83 Million USD | -41.66% |
| 2011 | -15.41 Million USD | -516.14% |
| 2010 | 3.7 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.77 Million USD | -19.72% |
| 2024 Q1 | -4.82 Million USD | 74.03% |
| 2023 Q4 | -18.56 Million USD | -50.25% |
| 2023 Q2 | -9.91 Million USD | -11.96% |
| 2023 FY | -49.69 Million USD | -70.44% |
| 2023 Q3 | -12.35 Million USD | -24.63% |
| 2023 Q1 | -8.85 Million USD | -5.45% |
| 2022 Q2 | -7.6 Million USD | -25.05% |
| 2022 Q3 | -7.07 Million USD | 6.89% |
| 2022 Q4 | -8.39 Million USD | -18.65% |
| 2022 FY | -29.15 Million USD | -17.68% |
| 2022 Q1 | -6.07 Million USD | 7.87% |
| 2021 Q1 | -5.44 Million USD | 7.2% |
| 2021 Q2 | -6.51 Million USD | -19.53% |
| 2021 Q4 | -6.59 Million USD | -6.13% |
| 2021 FY | -24.77 Million USD | -8.07% |
| 2021 Q3 | -6.21 Million USD | 4.54% |
| 2020 Q2 | -5.56 Million USD | 18.63% |
| 2020 Q4 | -5.87 Million USD | -26.31% |
| 2020 FY | -22.92 Million USD | 18.44% |
| 2020 Q3 | -4.64 Million USD | 16.48% |
| 2020 Q1 | -6.84 Million USD | 27.33% |
| 2019 Q2 | -6.47 Million USD | -16.12% |
| 2019 Q1 | -5.57 Million USD | 20.73% |
| 2019 FY | -28.11 Million USD | -9.79% |
| 2019 Q3 | -6.64 Million USD | -2.56% |
| 2019 Q4 | -9.41 Million USD | -41.7% |
| 2018 Q2 | -5.72 Million USD | 13.61% |
| 2018 FY | -25.6 Million USD | -1.45% |
| 2018 Q4 | -7.03 Million USD | -13.28% |
| 2018 Q3 | -6.21 Million USD | -8.47% |
| 2018 Q1 | -6.62 Million USD | 13.77% |
| 2017 Q2 | -5.19 Million USD | 2.02% |
| 2017 Q1 | -5.3 Million USD | -20.92% |
| 2017 FY | -25.24 Million USD | -52.85% |
| 2017 Q4 | -7.68 Million USD | -8.94% |
| 2017 Q3 | -7.05 Million USD | -35.87% |
| 2016 Q3 | -4.48 Million USD | -16.09% |
| 2016 FY | -16.51 Million USD | -1.96% |
| 2016 Q1 | -3.77 Million USD | 7.9% |
| 2016 Q2 | -3.86 Million USD | -2.38% |
| 2016 Q4 | -4.38 Million USD | 2.32% |
| 2015 FY | -16.19 Million USD | -2.18% |
| 2015 Q4 | -4.1 Million USD | -13.79% |
| 2015 Q3 | -3.6 Million USD | 13.51% |
| 2015 Q2 | -4.16 Million USD | 3.72% |
| 2015 Q1 | -4.32 Million USD | 2.28% |
| 2014 Q3 | -3.87 Million USD | 1.79% |
| 2014 Q2 | -3.94 Million USD | 3.03% |
| 2014 FY | -15.85 Million USD | 10.08% |
| 2014 Q1 | -4.07 Million USD | -34.3% |
| 2014 Q4 | -4.42 Million USD | -14.21% |
| 2013 Q2 | -4.59 Million USD | 29.31% |
| 2013 Q1 | -6.49 Million USD | 7.03% |
| 2013 Q4 | -3.03 Million USD | 6.63% |
| 2013 FY | -17.62 Million USD | 19.26% |
| 2013 Q3 | -3.24 Million USD | 29.31% |
| 2012 FY | -21.83 Million USD | -41.66% |
| 2012 Q3 | -4.97 Million USD | 2.2% |
| 2012 Q2 | -5.08 Million USD | 0.37% |
| 2012 Q1 | -5.1 Million USD | -21.87% |
| 2012 Q4 | -6.98 Million USD | -40.48% |
| 2011 Q1 | -2.87 Million USD | 41.09% |
| 2011 Q3 | -4.5 Million USD | -2.4% |
| 2011 Q4 | -4.18 Million USD | 7.09% |
| 2011 FY | -15.41 Million USD | -516.14% |
| 2011 Q2 | -4.4 Million USD | -53.28% |
| 2010 Q1 | -3.94 Million USD | 0.0% |
| 2010 Q2 | -7.93 Million USD | -101.39% |
| 2010 Q3 | 20.99 Million USD | 364.46% |
| 2010 Q4 | -4.87 Million USD | -123.23% |
| 2010 FY | 3.7 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Matricelf Ltd | -12.59 Million ILA | -294.522% |